Predictive value of ApoB/ApoA-I for recurrence within 1 year after first incident stroke

Jie Lin1, Zhihua Si2, Aihua Wang2

  • 1Department of Neurology, Shandong Provincial Qianfoshan Hospital, Shandong University, Shandong Institute of Neuroimmunology, Shandong Key Laboratory of Rheumatic Disease and Translational Medicine, Shandong, China.

Frontiers in Neurology
|January 26, 2024
PubMed

Insights

The ApoB/ApoA-I ratio, a key cholesterol balance indicator, predicts ischemic stroke recurrence. Higher ratios in acute stroke patients significantly correlate with increased stroke recurrence risk within one year.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Biochemistry

Background:

  • The apolipoprotein B (ApoB)/apolipoprotein A-I (ApoA-I) ratio is a recognized marker for assessing cholesterol balance.
  • This ratio is particularly valuable in predicting the risk of ischemic events.

Purpose of the Study:

  • To evaluate the prognostic capability of the ApoB/ApoA-I ratio.
  • To determine its association with stroke recurrence within one year following an initial ischemic stroke event.

Main Methods:

  • A retrospective analysis of 722 patients diagnosed with acute ischemic stroke.
  • Measurement of serum ApoB and ApoA-I levels upon admission.
  • Statistical analysis, including Kaplan-Meier curves and Cox regression, to assess the relationship between the ApoB/ApoA-I ratio and 1-year stroke recurrence.

Main Results:

  • A 14.1% rate of stroke recurrence within one year was observed.
  • Patients experiencing recurrence had significantly higher admission ApoB/ApoA-I ratios (P < 0.001).
  • The ApoB/ApoA-I ratio showed a significant positive correlation with 1-year stroke recurrence risk (HR 4.007), even after adjusting for traditional risk factors.

Conclusions:

  • The ApoB/ApoA-I ratio measured during the acute phase of a first stroke is a significant predictor of recurrent stroke within one year.
  • This association remained robust across different patient subgroups, including those with varying LDL-C levels and specific stroke types like Large Artery Atherosclerosis (LAA).
Abstract